Leads from global markets were not supportive either.
The selling took hold at the start of August futures and options (F&O) series in the derivatives segment, traders said.
The NSE index struggled and ended at 10,014.50, down 6.05 points, or 0.06 per cent, from the previous close after hitting a low of 9,944.50.
A spell of buying towards the end arrested the slide for the BSE Sensex, which closed lower by 73.42 points, or 0.23 per cent, at 32,309.88.
Both indices, however, registered gains for the week, their fourth straight weekly advance. From the week point of view, the Sensex climbed 280.99 points, or 0.87 per cent, while the Nifty gained 99.25 points, or 1 per cent.
It was a record-smashing week for both the indices, which scaled their lifetime highs.
The benchmark Sensex closed lower for the first time in last three trading sessions, hit by losses in pharma, metal, realty, capital goods and banking stocks.
"Soft July derivatives rollover figures amid weak global cues lent a weak bias to opening sentiment, but pullback from the PSU banks steadied the indices. Market is also expecting a rate cut from RBI's policy meeting next week, with the inflation figures at record low," said Anand James, Chief Market Strategist, Geojit Financial Services.
Dr Reddy's was the biggest drag, which crashed 6.08 per cent after the drug firm's consolidated net profit for the June quarter plunged. Lupin and Sun Pharma followed suit.
Shares of ICICI Bank too fell 3.60 per cent after the private bank reported a marginal rise in June quarter earnings.
Hero MotoCorp, L&T, Axis Bank, Hindustan Unilever, Coal India, all fell by up to 2.04 per cent.
Reliance Capital rose 8.84 per cent after 15 per cent growth in quarterly consolidated net profit.
The BSE healthcare index took the big knock, falling 1.73 per cent, followed by metal, realty and capital goods.
Broader markets managed to keep their head above water with gains.
Asian markets ended lower, dragged down by subdued US earnings and a drop in technology shares.
European stocks witnessed a subdued trend too.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
